NLS

AstraZeneca’s site in Mölndal will continue to be a global center for research and development, the company recently announced. At the same time, another 2 300 employees are being made redundant. The company plans to invest in strategic R&D centers in the UK, the US and Mölndal, Sweden, focusing on small molecule and biologics R&D […]

Swedish Genovis AB recently announced the signing of a new agreement with a major pharmaceutical company. Genovis has not revealed the name of the new business partner but announces that the one-year development project agreement is worth approximately 100 000 US dollars. The project will adapt their products from the protein characterization portfolio to the […]

Shire has acquired biotech company Premacure, developer of a drug to treat a rare eye disorder among premature infants.

Orion Corporation and Gedeon Richter Plc. have entered into a long term collaboration agreement for the discovery and development of new chemical entities in the field of cognitive disorders. According to the agreement the partnership provides an opportunity whereby the two companies jointly select and bring forward three discovery phase candidates and share all the […]

Stockholm-based BioLamina recently signed a new R&D agreement with Roche to develop novel cell culture systems. The systems will be aimed at various applications, including stem cell research. BioLamina’s and Roche’s collaboration will focus on assessing laminin-based in-vitro cell culture matrices offering highly physiological microenvironments for living cells. According to BioLamina, laminins are proteins located […]

In early March, medtech giant Getinge announced that the manufacturing of its bath and hygiene products are to be moved from Eslöv, south of Sweden, to the production facility in Poznan, Poland. The changes are according to the company part of its enhancement of Getinge’s operational efficiency by further concentrating its production to fewer units […]